Determination of landiolol in human plasma by high-performance liquid chromatography with fluorescence detection

Tohru Aomori, Naoki Matsumoto, Katsunori Nakamura, Yukiyoshi Fujita, Masayuki Sekizuka, Takuya Araki, Tomonori Nakamura, Koujirou Yamamoto

研究成果: Article査読

2 被引用数 (Scopus)

抄録

Landiolol is an ultra-short-acting β 1-adrenergic receptor-blocking agent that is used with perioperative patients who are at risk of cardiac events. The drug is hydrolyzed very rapidly by pseudocholinesterase in the blood. Using physostigmine (final concentration: 10 -4 mol/L) as a cholinesterase inhibitor, we developed a simple and rapid quantification method for landiolol using high-performance liquid chromatography. Chromatographic separations were achieved on a C 18 column with 20 mMKH 2PO 4/acetonitrile (70/30, v/v). Propranolol was used as an internal standard. The peaks were detected using a fluorescence detector (excitation 220 nm and emission 310 nm). The retention times of landiolol and propranolol were 5.6 min and 6.7 min, respectively. The lower limit of quantification was estimated as being 0.1 μg/mL. The precision of the inter-and intra-assay varied between 1.8% and 12.6%, and the accuracy varied between-8.1% and 7.7%. This method was useful for the determination of landiolol in human plasma after intravenous administration.

本文言語English
ページ(範囲)2411-2419
ページ数9
ジャーナルJournal of Liquid Chromatography and Related Technologies
34
19
DOI
出版ステータスPublished - 2011
外部発表はい

ASJC Scopus subject areas

  • 分析化学
  • 生化学
  • 薬科学
  • 臨床生化学

フィンガープリント

「Determination of landiolol in human plasma by high-performance liquid chromatography with fluorescence detection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル